Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Gerresheimer makes solid start to the financial year 2024 – Biotech Investments
EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement Gerresheimer makes solid start to the financial year 2024 11.04.2024 / 07:00 CET/CEST The issuer